Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $151,439 | $67,523 | $80,994 | $136,942 |
| - Cash | $52,373 | $40,368 | $56,255 | $25,512 |
| + Debt | $28,840 | $29,427 | $29,240 | $715 |
| Enterprise Value | $127,906 | $56,582 | $53,979 | $112,145 |
| Revenue | $15,615 | $10,114 | $0 | $39 |
| % Growth | 54.4% | – | -100% | – |
| Gross Profit | $14,552 | $8,322 | -$3 | -$3 |
| % Margin | 93.2% | 82.3% | – | -7.7% |
| EBITDA | -$4,063 | -$10,828 | -$21,732 | -$28,841 |
| % Margin | -26% | -107.1% | – | -73,951.3% |
| Net Income | -$5,143 | -$8,939 | -$21,929 | -$29,045 |
| % Margin | -32.9% | -88.4% | – | -74,474.4% |
| EPS Diluted | -0.026 | -0.049 | -0.12 | -0.17 |
| % Growth | 47.7% | 59.3% | 29.4% | – |
| Operating Cash Flow | -$21,440 | -$25,338 | -$17,909 | -$23,446 |
| Capital Expenditures | -$108 | -$228 | $0 | -$6 |
| Free Cash Flow | -$21,548 | -$25,566 | -$17,909 | -$23,452 |